Law & Policy

·

Policy

DEA Sends Psilocybin Rescheduling Petition to Health Officials

DEA Sends Psilocybin Rescheduling Petition to Health Officials

Psilocybin mushrooms

What they found

The DEA sent HHS a petition to review moving psilocybin from Schedule I to Schedule II.

The DEA sent HHS a petition to review moving psilocybin from Schedule I to Schedule II.

How solid is it?

n/a

n/a

Not a study

Not a study

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Compound

psilocybin

psilocybin

Published in

Marijuana Moment

Marijuana Moment

Covered in Shroom Scan

Section

PSILOCYBIN & LEGISLATION

PSILOCYBIN & LEGISLATION

As it ran in Shroom Scan

DEA Advances Psilocybin Rescheduling

DEA Advances Psilocybin Rescheduling

After years of legal back-and-forth, the DEA has formally sent a petition to the Department of Health and Human Services to review moving psilocybin from Schedule I to Schedule II. The case, led by Dr. Sunil Aggarwal for end-of-life care patients, marks a key step toward potential medical access. If HHS and FDA recommend rescheduling, psilocybin could become available under Right to Try laws for terminally ill patients and veterans at risk of suicide.

After years of legal back-and-forth, the DEA has formally sent a petition to the Department of Health and Human Services to review moving psilocybin from Schedule I to Schedule II. The case, led by Dr. Sunil Aggarwal for end-of-life care patients, marks a key step toward potential medical access. If HHS and FDA recommend rescheduling, psilocybin could become available under Right to Try laws for terminally ill patients and veterans at risk of suicide.

Veterans Heal, Rivers Recover, and Mushroom Blends May Be Better

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.